Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Biologics Safety Testing Market by Product, Test, Application - Global Forecast to 2022 - Key Players are Lonza Group, Charles River Laboratories, Merck KGaA & SGS SA - Research and Markets

Research and Markets
Posted on: 26 Jul 17

The "Biologics Safety Testing Market by Product, Test, Application - Global Forecast to 2022" report has been added to Research and Markets' offering.

The biologics safety testing market was valued at USD 2.75 billion in 2017 and expected to grow at a CAGR of 12.2% to a USD 4.90 billion market by 2022. Growth in pharmaceutical and biotechnology industry driven by government support, the positive trend of R&D investment in the life science industry, and an increase in the number of new drug launches are factors driving the growth of this market. On the other hand, the time-consuming approval process for new drugs is considered a restraint for the market.

The biologics safety testing market is classified on the basis of product & service into kits & reagents, services, and instruments. The kits & reagents segment is expected to register highest growth rate during the forecast period. This growth can be attributed to the reoccurring purchase of kits & reagents, which is required for running tests.

The biologics safety testing market is classified by test type into endotoxin tests, sterility tests, cell line authentification and characterization tests, residual host contamination detection tests, adventitious agent detection tests, bioburden tests, and other tests. The endotoxin tests segment is expected to register the highest growth rate during the forecast period. This growth can be attributed to the increase in the number of drug launches.

Companies Mentioned

  • Avance Biosciences Inc.
  • Biomérieux Sa
  • Bsl Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Clean Cells
  • Cytovance Biologics
  • Eurofins Scientific Se
  • F. Hoffmann-La Roche Ltd.
  • Genscript
  • Gibraltar Laboratories
  • Invivogen
  • Lonza Group Ltd
  • Merck KGaA
  • Neopharm Labs Inc.
  • North American Science Associates Inc.
  • Pace Analytical Services Inc.
  • Promocell GmbH
  • SGS S.A.
  • Sartorius AG
  • Source Bioscience
  • Sterigenics International LLC
  • Thermo Fisher Scientific Inc.
  • Toxikon Corporation
  • Virusure GmbH
  • Wuxi Apptec

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Biologics Safety Testing Market: Premium Insights

5 Market Overview

6 Biologics Safety Testing Market, By Product and Service

7 Biologics Safety Testing Market, By Test Type

8 Biologics Safety Testing Market, By Application

9 Biologics Safety Testing Market, By Region

10 Competitive Landscape

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/5q6tcr/biologics_safety

View source version on businesswire.com: http://www.businesswire.com/news/home/20170726005609/en/

Business Wire
www.businesswire.com

Last updated on: 26/07/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.